Ref ID: 18419
Author:
Rosana Blavia, Antonia Flor , Isabel Serra, Montse Morta, Dolores Estivill3,
Ramon Trullas, Damian Perich, Esperanza Martin, Conxa Perez,
Emilio Marquilles
Author address:
Pulmonology, Manresa Hospital – Althaia, Manresa,
Barcelona, Spain; Internal Medicine, Manresa Hospital – Althaia, Manresa,
Barcelona, Spain; Microbiology, Manresa Hospital – Althaia, Manresa,
Barcelona, Spain; Radiology, Manresa Hospital – Altahi
Full conference title:
European Respiratory Congress
Abstract:
This retrospective study included patients with chronic respiratory disease with
aspergillus isolation in respiratory cultures from Jan-07 to Dec-09. The diagnosis
of probable invasive pulmonary aspergillus (IPA) was based on compatible clinical
setting and HRCT findings. A univariate comparative analysis between IPA
probable and aspergillar colonization was carried out.
Results: Of the 103 patients registered 66 patients were excluded. Of the remaining
37 we diagnosed 15 patients (14%) with IPA probable and 22 (21%) as
colonization. COPD in 73% of patients (80% GOLD III-IV). The prior use of
corticosteroids was higher in IPA, with a greater accumulate mean 405 mgr in IPA
v 74 mgr in colonizated (p<0.05). A greater number of hospital admissions were
detected in IPA. The mean length of hospital stay was higher in IPA with 35±28 days as opposed to 13±22 d. in colonization (p:0.003) and respiratory failure (80%
IPA v 36% p:0.009). Antifungal therapy was received by 91% of IPA and by 36%
of colonized. The overall mortality rate was 47% in IPA and 23% in colonization.
Conclusions: 1. Immunosupression by corticosteroids in COPD patients Gold
III-IV is the major risk factor for invasive aspergillosis.2. The absence of clinical
improvement in correctly treated exacerbations of severe COPD and recurrent
isolation of aspergillus in sputum should point to the possibility of the existence of
IPA and demand a HRCT scan.3. HRCT findings can detect early IPA in the shape
of bronchial spread once bacterial or mycobacterial infections have been ruled out.
Abstract Number: P3025
Conference Year: 2011
Link to conference website: http://www.ers-education.org/ersMade/abstract_print_11/files/Abstract_book_2011.pdf
New link: NULL
Conference abstracts, posters & presentations
-
Title
Author
Year
Number
Poster
-
v
Teclegiorgis Gebremariam [MS]1, Yiyou Gu [PhD]1, Sondus Alkhazraji [PhD]1, Jousha Quran1, Laura K. Najvar [BS]2, Nathan P. Wiederhold [PharmD]2, Thomas F. Patterson [MD]2, Scott G. Filler [MD]1,3, David A. Angulo (MD)4, Ashraf S. Ibrahim [PhD]1,3*,
2024
91
n/a
-
v
Ruta Petraitiene (US)
2024
90
n/a
-
v
Fabio Palmieri (CH), Junier Pilar
2024
89
n/a
-
v
Evelyne Côté (CA)
2024
88
n/a
-
v
Eliane Vanhoffelen (BE)
2024
87
n/a
-
v
Teclegiorgis Gebremariam, Yiyou Gu, Eman Youssef, Sondus Alkhazraji, Joshua Quran, Nathan P. Wiederhold, Ashraf S. Ibrahim
2024
86
n/a
-
v
Thomas Orasch (DE)
2024
85
n/a
-
v
Julien Alex, Katherine González, Gauri Gangapurwala, Antje Vollrath, Zoltán Cseresnyés, Christine Weber, Justyna A. Czaplewska, Stephanie Hoeppener, Carl-Magnus Svensson, Thomas Orasch, Thorsten Heinekamp, Carlos Guerrero-Sánchez, Marc Thilo Figge, Ulrich S. Schubert, Axel A. Brakhage
2024
84
n/a
-
v
Vasireddy Teja, Bibhuti Saha Hod, Soumendranath Haldar (IN)
2024
83
n/a
-
v
Vasireddy Teja, Bibhuti Saha Hod, Soumendranath Haldar (IN)
2024
82
n/a